Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Exchange Rate Effect (2016 - 2025)

IGC Pharma (IGC) has disclosed Exchange Rate Effect for 16 consecutive years, with $5000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect rose 145.45% to $5000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $32000.0, a 633.33% increase, with the full-year FY2025 number at -$7000.0, down 16.67% from a year prior.
  • Exchange Rate Effect was $5000.0 for Q3 2025 at IGC Pharma, down from $25000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $25000.0 in Q2 2025 to a low of -$52000.0 in Q2 2022.
  • A 5-year average of -$5111.1 and a median of $1000.0 in 2023 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: crashed 3900.0% in 2022, then surged 1150.0% in 2025.
  • IGC Pharma's Exchange Rate Effect stood at $14000.0 in 2021, then plummeted by 192.86% to -$13000.0 in 2022, then skyrocketed by 107.69% to $1000.0 in 2023, then plummeted by 1200.0% to -$11000.0 in 2024, then soared by 145.45% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Exchange Rate Effect are $5000.0 (Q3 2025), $25000.0 (Q2 2025), and $2000.0 (Q1 2025).